These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33674226)

  • 1. When Eating Becomes a Pain in the Gut.
    Adair T; Belz GT
    Trends Immunol; 2021 Apr; 42(4):273-275. PubMed ID: 33674226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
    Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroacupuncture Relieves Irritable Bowel Syndrome by Regulating IL-18 and Gut Microbial Dysbiosis in a Trinitrobenzene Sulfonic Acid-Induced Post-Inflammatory Animal Model.
    Song YF; Pei LX; Chen L; Geng H; Yuan MQ; Xu WL; Wu J; Zhou JY; Sun JH
    Am J Chin Med; 2020; 48(1):77-90. PubMed ID: 31918565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term functional consequences of acute infectious diarrhea.
    Cocciolillo S; Collins SM
    Curr Opin Gastroenterol; 2016 Jan; 32(1):1-6. PubMed ID: 26628101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bacteria on the enteric nervous system: implications for the irritable bowel syndrome.
    Wood JD
    J Clin Gastroenterol; 2007; 41 Suppl 1():S7-19. PubMed ID: 17438418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The putative role of the intestinal microbiota in the irritable bowel syndrome.
    Collins SM; Denou E; Verdu EF; Bercik P
    Dig Liver Dis; 2009 Dec; 41(12):850-3. PubMed ID: 19740713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients.
    Zhou XY; Li M; Li X; Long X; Zuo XL; Hou XH; Cong YZ; Li YQ
    World J Gastroenterol; 2016 Jun; 22(22):5211-27. PubMed ID: 27298564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast Cell Regulation and Irritable Bowel Syndrome: Effects of Food Components with Potential Nutraceutical Use.
    Uranga JA; Martínez V; Abalo R
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32962285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of the irritable bowel syndrome - Reflections of today.
    Hellström PM
    Best Pract Res Clin Gastroenterol; 2019; 40-41():101620. PubMed ID: 31594651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track.
    Rinninella E; Cintoni M; Raoul P; Gasbarrini A; Mele MC
    Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33260947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
    Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
    J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut-Brain-Microbiota Axis: Antibiotics and Functional Gastrointestinal Disorders.
    Karakan T; Ozkul C; Küpeli Akkol E; Bilici S; Sobarzo-Sánchez E; Capasso R
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33513791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.
    Pearson JS; Whorwell PJ
    Curr Opin Gastroenterol; 2017 Jan; 33(1):21-25. PubMed ID: 28134688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation of enteric neural function in irritable bowel syndrome.
    O'Malley D
    World J Gastroenterol; 2015 Jun; 21(24):7362-6. PubMed ID: 26139983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study.
    Xu XJ; Zhang YL; Liu L; Pan L; Yao SK
    Aliment Pharmacol Ther; 2017 Jan; 45(1):100-114. PubMed ID: 27862119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.